IpiNovyx Bio

Private

New York City, New YorkHealthcare & Life Scienceshttps://www.ipinovyx.com/

Last Round

Seed

Oct 5, 2021

Total Funding Raised

$10M

Company Overview

IpiNovyx Bio is a biotechnology company developing a platform of selective and reversible immunoproteasome inhibitors to treat cancer, autoimmune, and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

immunoproteasome inhibitorssmall-molecule drugsdrug discoverybiotechoncologyautoimmune diseasepreclinical developmenttherapeutic pipelinedrug developmentinflammatory diseasebiopharmadrug candidatemedicinal chemistryproteasome modulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

IpiNovyx Bio Comparables

Compare IpiNovyx Bio with similar companies based on industry and business-model similarity.

IpiNovyx Bio comparables — related companies by embedding similarity
Company	Similarity	Market Cap
iProtics	88%
QLi5 Therapeutics GmbH	82%
Enodia Therapeutics	71%

View all Comparables

IpiNovyx Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Oct 5, 2021

View all Funding Rounds

IpiNovyx Bio Investors

Notable investors and investment history

IpiNovyx Bio investors
Investor	Rounds
Viva BioInnovator	Seed
Alexandria Venture Investments	Seed

View all Investors

IpiNovyx Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

IpiNovyx Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about IpiNovyx Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York

Year Founded2021

Last FundingOct 5, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?